热门资讯> 正文
Atea Pharmaceuticals宣布股票回购计划
2025-04-17 20:07
- Atea Pharmaceuticals (NASDAQ:AVIR) announced on Thursday the appointment of Howard H. Berman to its board.
- Atea also announced that its board has authorized, and will promptly begin executing upon, the repurchase of up to $25M of the company’s common stock.
- Atea Pharmaceuticals (NASDAQ:AVIR) shares were up more than 3% in premarket trading.
More on Atea Pharmaceuticals
- Atea Pharmaceuticals, Inc. (AVIR) Q4 2024 Earnings Call Transcript
- Atea Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Atea Pharmaceuticals
- Historical earnings data for Atea Pharmaceuticals
- Financial information for Atea Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。